Search Results
1 - 12 of 12 matches
Ischemia, Orbita, Courage trials will bring down Coronary Revascularization Significantly
Presenter:
Baren Chakraborty
February 2, 2020
Case #5: This is Why OCT is Encouraged by EBC for Complex Bifurcations
Presenter:
Jens Flensted Lassen
November 1, 2016
For This Patient, I Suggest Medical Management and Risk-Factor Reduction Alone (What Have COURAGE and FAME Taught Us?)
Presenter:
John D. Puskas, Michael E. Farkouh
October 14, 2015
HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Clinicians Perspective
Presenter:
Ajay J. Kirtane, Bernard J. Gersh, William S. Weintraub
October 12, 2015
HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Guideline Perspective
Presenter:
Bernard J. Gersh, Patrick T. O'Gara, William S. Weintraub
October 12, 2015
From COURAGE and BARI 2D to ISCHEMIA: What Answers Can We Expect (and Not Expect) From ISCHEMIA?
Presenter:
Ajay J. Kirtane, Ori Ben-Yehuda, Sripal Bangalore
October 11, 2015
On the PROSPECT of Reconciling COURAGE and FAME
Presenter:
Jagat Narula
October 30, 2013
The Fate of PCI for Multi-Vessel Disease From COURAGE to Syntax
Presenter:
Seung-Jung Park
April 24, 2013
Is There Sufficient Evidence To Discourage The Use Of Multi-Vessel Angioplasty During STEMI? An Analysis of 35,008 Patients
Presenter:
Alun Hughes, Darrel Francis, Ghada Mikhail, Iqbal Malik, Justin Davies, Nearchos Hadjiloizou, Nicolas Foin, Ricardo Petraco, Rodney Foale, Sayan Sen, Sukhjinder Nijjer
January 31, 2013
Are COURAGE and FAME Irrelevant (or Less Relevant) with Current Generation DES?
Presenter:
Dean Kereiakes
October 22, 2012
The Impact of XIENCE V® Everolimus-Eluting Coronary Stents on Health Status in COURAGE-Like Patients.
Presenter:
David R. Rutledge, James B. Hermiller, Jin Wang, Mitchell W. Krucoff
January 3, 2012